Premium
P4‐324: Effects of oral ELND005 (scyllo‐inositol) on neuropsychiatric symptoms in a 78‐week phase 2 study in mild/moderate Alzheimer's disease (AD): Potential role of myo‐inositol reduction
Author(s) -
Lyketsos Constantine,
Abushakra Susan,
Liang Earvin,
Hernandez Ramon,
Tariot Pierre,
Porsteinsson Anton,
Wagg Jonathan
Publication year - 2012
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2013.08.105
Subject(s) - apathy , inositol , irritability , placebo , depression (economics) , medicine , anxiety , quartile , disinhibition , psychology , logistic regression , endocrinology , gastroenterology , psychiatry , disease , pathology , receptor , confidence interval , alternative medicine , economics , macroeconomics